Categories Earnings, Technology

Weakness in Europe pulls down Stratasys Q2 revenues

Stratasys (NASDAQ: SSYS) a leading manufacturer of 3D printers, on Wednesday, reported 4% slip in second-quarter revenues to $163.2 million, lower than the Wall Street projection of $168.7 million. The revenues were hurt by the economic weakness in Europe, impacting general spending in the automotive and industrial machinery markets.

Net income was 16 cents per share, compared to 15 cents per share it reported in the year-over period. The Q2 EPS was a cent higher than the analysts’ estimate.

Interim CEO Elan Jaglom said, “We believe that we are well positioned to return to growth in Europe when macro conditions improve, and our new products and platforms are launched and adopted in the market.”

The Israeli company ended its last trading session down 0.32% on Tuesday.  SSYS shares have gained 51.8% in the year-to-date period and 46% in the trailing 12 months.    

READ: Samsung dips on weak memory chip price in Q2

Outlook

For fiscal 2019, the company expects revenues of $670 to $700 million. Guidance on GAAP net loss for this period was lowered to 5-31 cents per share, from the earlier guidance of 22-40 cents per share.

Excluding one-off items, net income for the full year is projected to hit 55-70 cents per share.

Rival 3D Systems (NYSE: DDD) is scheduled to report second-quarter financial results on August 7.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top